ADHD symptoms – inattention, parent‐rated – medium term · Children and adolescents with ADHD
1 finding from 1 review
ADHD symptoms – hyperactivity/impulsivity, parent‐rated – medium term · Children and adolescents with ADHD
1 finding from 1 review
Side effects – overall · Children and adolescents with ADHD
Summary of findings table ‐ PUFA showed no clear difference in side effects – overall compared with placebo (moderate certainty).
1 finding from 1 review
Loss to · Children and adolescents with ADHD
Summary of findings table ‐ PUFA showed no clear difference in loss to compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in all‐cause mortality compared with no zinc supplementation (high certainty).
1 finding from 1 review
Mortality due to all‐cause diarrhea · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in mortality due to all‐cause diarrhea compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
Mortality due to LRTI · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in mortality due to LRTI compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
Mortality due to malaria · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in mortality due to malaria compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
Diarrhea · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation probably leads to lower incidence of all‐cause diarrhea compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
Incidence of LRTI · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation showed no clear difference in incidence of LRTI compared with no zinc supplementation (high certainty).
1 finding from 1 review
Height (cm) · otherwise healthy children aged 6 months to 12 years of age
1 finding from 1 review
Participants with ≥ 1 vomiting episode · otherwise healthy children aged 6 months to 12 years of age
Zinc supplementation leads to higher participants with ≥ 1 vomiting episode compared with no zinc supplementation (high certainty).
1 finding from 1 review
ADHD symptoms · Children and adolescents with ADHD
It is very uncertain whether methylphenidate changes ADHD symptoms: all parallel‐group trials and first‐period cross‐over… compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Proportion of participants with one or more serious adverse events · Children and adolescents with ADHD
It is very uncertain whether methylphenidate changes proportion of participants with one or more serious adverse events compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events considered non‐serious (penicillin versus doxycycline) · Children and adolescents with ADHD
It is very uncertain whether methylphenidate changes proportion of participants with one or more adverse events… compared with placebo or no intervention (very low certainty).
1 finding from 1 review
General behaviour: all parallel‐group trials and first‐period cross‐over trials General behaviour rating scales (Teacher‐rated) · Children and adolescents with ADHD
It is very uncertain whether methylphenidate changes general behaviour: all parallel‐group trials and first‐period… compared with placebo or no intervention (very low certainty).
1 finding from 1 review
QoL · Children and adolescents with ADHD
It is very uncertain whether methylphenidate changes quality of life (parent‐rated) compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Irritability · participants (any age) with a clinical diagnosis of ASD who have displayed one or more unwanted or challenging behaviours at baseline…
1 finding from 1 review
Aggression · participants (any age) with a clinical diagnosis of ASD who have displayed one or more unwanted or challenging behaviours at baseline…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Self‐injury · participants (any age) with a clinical diagnosis of ASD who have displayed one or more unwanted or challenging behaviours at baseline…
1 finding from 1 review